Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alain Viari

Showing results (41-50 of 77) with videos related to

Pageof 8
Sort By:
European Urology|September 25, 2018
Mutational Profile of Aggressive, Localised Prostate Cancer from African Caribbean Men Versus European Ancestry MenLaurie Tonon, Gaëlle Fromont, Sandrine Boyault, et al.
Oncoimmunology|December 8, 2018
Immunological and classical subtypes of oral premalignant lesionsJean-Philippe Foy, Chloé Bertolus, Sandra Ortiz-Cuaran, et al.
Journal of Hepatology|June 21, 2019
Toll-like receptor 3 downregulation is an escape mechanism from apoptosis during hepatocarcinogenesisMarc Bonnin, Nadim Fares, Barbara Testoni, et al.
Cancer Research Communications|September 14, 2023
An Early Neoplasia Index (ENI10), Based on Molecular Identity of CD10 Cells and Associated Stemness Biomarkers, is a Predictor of Patient Outcome in Many CancersBoris Guyot, Flora Clément, Youenn Drouet, et al.
Journal of Hepatology|November 30, 2019
Corrigendum to "Toll-like receptor 3 downregulation is an escape mechanism from apoptosis during hepatocarcinogenesis" [J Hepatol 71 (2019) 763-772]Marc Bonnin, Nadim Fares, Barbara Testoni, et al.
Infection, Genetics and Evolution : Journal of Molecular Epidemiology and Evolutionary Genetics in Infectious Diseases|June 12, 2012
Dynamic of H5N1 virus in Cambodia and emergence of a novel endemic sub-cladeSan Sorn, Touch Sok, Sovann Ly, et al.
Communications Biology|October 7, 2022
SMAD2/3 mediate oncogenic effects of TGF-β in the absence of SMAD4Adrien Bertrand-Chapel, Cassandre Caligaris, Tanguy Fenouil, et al.
Cancers|July 14, 2023
Sorafenib in Molecularly Selected Cancer Patients: Final Analysis of the MOST-Plus Sorafenib CohortOlivier Trédan, Maud Toulmonde, Christophe Le Tourneau, et al.
Journal of Personalized Medicine|October 27, 2022
Alterations in Homologous Recombination-Related Genes and Distinct Platinum Response in Metastatic Triple-Negative Breast Cancers: A Subgroup Analysis of the ProfiLER-01 TrialElise Bonnet, Véronique Haddad, Stanislas Quesada, et al.
Nature Medicine|April 8, 2025
Broad versus limited gene panels to guide treatment in patients with advanced solid tumors: a randomized controlled trialOlivier Trédan, Damien Pouessel, Nicolas Penel, et al.
Pageof 8

Showing results (41-50 of 77) with videos related to

Sort By:
Pageof 8
European Urology|September 25, 2018
Mutational Profile of Aggressive, Localised Prostate Cancer from African Caribbean Men Versus European Ancestry MenLaurie Tonon, Gaëlle Fromont, Sandrine Boyault, et al.
Oncoimmunology|December 8, 2018
Immunological and classical subtypes of oral premalignant lesionsJean-Philippe Foy, Chloé Bertolus, Sandra Ortiz-Cuaran, et al.
Journal of Hepatology|June 21, 2019
Toll-like receptor 3 downregulation is an escape mechanism from apoptosis during hepatocarcinogenesisMarc Bonnin, Nadim Fares, Barbara Testoni, et al.
Cancer Research Communications|September 14, 2023
An Early Neoplasia Index (ENI10), Based on Molecular Identity of CD10 Cells and Associated Stemness Biomarkers, is a Predictor of Patient Outcome in Many CancersBoris Guyot, Flora Clément, Youenn Drouet, et al.
Journal of Hepatology|November 30, 2019
Corrigendum to "Toll-like receptor 3 downregulation is an escape mechanism from apoptosis during hepatocarcinogenesis" [J Hepatol 71 (2019) 763-772]Marc Bonnin, Nadim Fares, Barbara Testoni, et al.
Infection, Genetics and Evolution : Journal of Molecular Epidemiology and Evolutionary Genetics in Infectious Diseases|June 12, 2012
Dynamic of H5N1 virus in Cambodia and emergence of a novel endemic sub-cladeSan Sorn, Touch Sok, Sovann Ly, et al.
Communications Biology|October 7, 2022
SMAD2/3 mediate oncogenic effects of TGF-β in the absence of SMAD4Adrien Bertrand-Chapel, Cassandre Caligaris, Tanguy Fenouil, et al.
Cancers|July 14, 2023
Sorafenib in Molecularly Selected Cancer Patients: Final Analysis of the MOST-Plus Sorafenib CohortOlivier Trédan, Maud Toulmonde, Christophe Le Tourneau, et al.
Journal of Personalized Medicine|October 27, 2022
Alterations in Homologous Recombination-Related Genes and Distinct Platinum Response in Metastatic Triple-Negative Breast Cancers: A Subgroup Analysis of the ProfiLER-01 TrialElise Bonnet, Véronique Haddad, Stanislas Quesada, et al.
Nature Medicine|April 8, 2025
Broad versus limited gene panels to guide treatment in patients with advanced solid tumors: a randomized controlled trialOlivier Trédan, Damien Pouessel, Nicolas Penel, et al.
Pageof 8